Page last updated: 2024-09-05

l 366948 and phenylpropanolamine

l 366948 has been researched along with phenylpropanolamine in 1 studies

*Phenylpropanolamine: A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant. [MeSH]

*Phenylpropanolamine: A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant. [MeSH]

Compound Research Comparison

Studies
(l 366948)
Trials
(l 366948)
Recent Studies (post-2010)
(l 366948)
Studies
(phenylpropanolamine)
Trials
(phenylpropanolamine)
Recent Studies (post-2010) (phenylpropanolamine)
12001,861369222

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McMahon, LR; Wellman, PJ1

Other Studies

1 other study(ies) available for l 366948 and phenylpropanolamine

ArticleYear
Assessment of the role of oxytocin receptors in phenylpropanolamine-induced anorexia in rats.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 57, Issue:4

    Topics: Animals; Anorexia; Appetite Depressants; Dose-Response Relationship, Drug; Drinking; Eating; Hormone Antagonists; Male; Peptides, Cyclic; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin

1997